Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**3-Fluoro-L-tyrosine** is a synthetic amino acid derivative and a non-proteinogenic analog of L-tyrosine. It features a fluorine atom at the 3-position of the aromatic ring, which enhances its metabolic stability and specificity for certain biological targets. This compound is primarily used in pharmaceutical and biochemical research as a building block for novel drug development, in neuroscience to study neurotransmitter pathways (notably dopamine), and as an imaging agent in oncology due to its preferential uptake by tumor cells. Mechanistically, it acts by inhibiting superoxide dismutase [mn], mitochondrial, reducing oxidative stress in cells. It is also transported into cells via the L-type amino acid transporter 1 (LAT1), which is often upregulated in malignant tumors—making it useful as a PET radiotracer for tumor imaging[1][2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 3-fluoro-L-tyrosine.